The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder (ASD)

March 22, 2021 updated by: Katie White, Institute of Technology, Carlow

The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism

The aim of the questionnaire and semi structured interview was to understand how the Covid 19 pandemic has impacted the cardiovascular health, physical activity levels, sedentary behavior, sleep, anxiety levels and eating habits of children with ASD in comparison to before the pandemic.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

A questionnaire was designed and was available for completion on the colleges survey monkey account. The link for the questionnaire and an explanation of the purpose of the questionnaire was e-mailed to relevant Autism charities or groups within Ireland, the UK and the USA and the administrators of these group were requested to send the link for the questionnaire onto their members. The administrators of relevant social media sites such as Facebook Autism groups were contacted and asked for permission to share the link for the questionnaire to be circulated on their Facebook page.

The questionnaire was completed by parents of children with ASD and consisted of questions relating to them and their child. Within the questionnaire they were asked about their socio-economic background and about their ASD child's cardiovascular health, physical activity levels, sedentary behavior, eating habits and anxiety levels during the Covid 19 pandemic compared to normal life before the outbreak of the pandemic. The aim of the questionnaire was to understand how the Covid 19 pandemic has impacted the cardiovascular health, physical activity levels, sedentary behavior, sleep, anxiety levels and eating habits in comparison to before the pandemic.

The questionnaires was completed online through IT Carlow's survey monkey. Individual results were anonymous and results of the questionnaire were stored on a password protected computer. Participants completed a consent form that explained that participation in the survey was completely voluntary and they could withdraw at any stage if they wished to do so. If they did not wish to answer a question, was a prefer not to say option available and they could continue with the survey. Parents had an option at the end of the survey to enter their email address which allowed them to partake in any follow up questionnaire studies. The questionnaire was initially piloted and was amended as necessary based on the results of the pilot study.

The second aspect will of the study used qualitative design (semi-structured interviews, n=10) to gain deeper insights into the challenges and barriers to engaging children with autism in healthy lifestyle behaviours and the effects COVID 19 had on these challenges and barriers. Each interview was approximately 60 minutes in length. A semi-structured, qualitative interview schedule, which is attached below guided the interview process and was continually revised based on reflection and evolving conceptualisation. Written consent was sought from all participants. The consent form explained that participation in the interview was completely voluntary and they could withdraw at any stage if they wished to do so. If they did not wish to answer a question, they could decline and move on to the next question. The interview was initially piloted and was amended as necessary based on the results of the pilot study.

Study Type

Observational

Enrollment (Anticipated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ireland
    • Lenister
      • Carlow, Lenister, Ireland
        • Institute of Technology Carlow

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

child with ASD of school going age living in Ireland, UK and USA.

Description

Inclusion Criteria:

  • children with ASD

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
child with ASD of school going age
Questionnaire complete by parent with children with ASD semi structure interview complete by parent with children
Other: The Effects of Covid 19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder
The Effects of Covid 19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder
Other Names:
  • Questionnaire study
  • Interview study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Effects of Covid-9 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder
Time Frame: 24 months
Questionnaire, interview
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Institute of Technology, Carlow

Investigators

  • Principal Investigator: Katie White, Institute of Technology, Carlow

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2019

Primary Completion (Anticipated)

October 14, 2021

Study Completion (Anticipated)

October 14, 2021

Study Registration Dates

First Submitted

March 2, 2021

First Submitted That Met QC Criteria

March 22, 2021

First Posted (Actual)

March 23, 2021

Study Record Updates

Last Update Posted (Actual)

March 24, 2021

Last Update Submitted That Met QC Criteria

March 22, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Institute Technology Carlow

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on The Effects of Covid 19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe